We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-8.85%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.16B
AUM Growth
-$246M
Cap. Flow
-$108M
Cap. Flow %
-9.27%
Top 10 Hldgs %
23.33%
Holding
205
New
58
Increased
35
Reduced
52
Closed
59

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$22.3M
2
VNT icon
Vontier
VNT
+$21.7M
3
SSNC icon
SS&C Technologies
SSNC
+$21.3M
4
IPGP icon
IPG Photonics
IPGP
+$21.3M
5
BKNG icon
Booking.com
BKNG
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 30.14%
2 Consumer Discretionary 16.46%
3 Communication Services 11.87%
4 Industrials 9.35%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AA icon
126
Alcoa
AA
$13.6B
$1.76M 0.15%
+52,391
New +$2.45M
RRGB icon
127
Red Robin
RRGB
$150M
$1.57M 0.13%
232,673
+60,733
+35% +$495K
DHIL
128
DELISTED
Diamond Hill
DHIL
$1.55M 0.13%
9,388
-4,402
-32% -$780K
MRC
129
DELISTED
MRC Global
MRC
$1.54M 0.13%
+214,181
New +$2.11M
SGC icon
130
Superior Group of Companies
SGC
$206M
$1.52M 0.13%
+170,785
New +$2.46M
ILLM
131
DELISTED
illumin Holdings Inc. Common Shares
ILLM
$1.37M 0.12%
787,484
-21,946
-3% -$51.3K
TASK icon
132
TaskUs
TASK
$651M
$1.24M 0.11%
+76,781
New +$1.36M
FDX icon
133
FedEx
FDX
$76.9B
$1.22M 0.1%
+8,188
New +$1.73M
MU icon
134
Micron Technology
MU
$972B
$1.2M 0.1%
+23,974
New +$1.39M
ARNC
135
DELISTED
Arconic Corporation
ARNC
$1.17M 0.1%
+68,821
New +$1.79M
LEXX icon
136
Lexaria Bioscience
LEXX
$9.07M
$1.16M 0.1%
31,540
+7,193
+30% +$307K
SMG icon
137
ScottsMiracle-Gro
SMG
$3.63B
$1.16M 0.1%
27,120
-8,003
-23% -$575K
PHX
138
DELISTED
PHX Minerals
PHX
$1.15M 0.1%
355,971
-10,093
-3% -$32.5K
DXPE icon
139
DXP Enterprises
DXPE
$2.99B
$1.14M 0.1%
+48,176
New +$1.38M
SHC icon
140
Sotera Health
SHC
$5.41B
$996K 0.09%
+146,038
New +$2.43M
QDEL icon
141
QuidelOrtho
QDEL
$938M
$963K 0.08%
+13,470
New +$1.21M
MAGN
142
Magnera Corp
MAGN
$466M
$945K 0.08%
+23,378
New +$1.63M
STRT icon
143
STRATTEC Security
STRT
$349M
$847K 0.07%
40,699
-1,071
-3% -$29.9K
DMTK
144
DELISTED
DermTech, Inc. Common Stock
DMTK
$828K 0.07%
209,175
-848,671
-80% -$5.22M
HYRE
145
DELISTED
HyreCar Inc. Common Stock
HYRE
$463K 0.04%
502,881
-460,655
-48% -$430K
CVT
146
DELISTED
Cvent Holding Corp. Common Stock
CVT
$234K 0.02%
+44,558
New +$253K
ABNB icon
147
Airbnb
ABNB
$111B
-46,729
Closed -$4.16M
ACVA icon
148
ACV Auctions
ACVA
$1.27B
-1,171,623
Closed -$7.66M
AGS
149
DELISTED
PlayAGS
AGS
-433,081
Closed -$2.23M
AXTA icon
150
Axalta
AXTA
$8.01B
-431,272
Closed -$9.54M

Similar funds

Invenomic Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Invenomic Capital Management held 205 positions worth $1.16B, down 17% from $1.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Invenomic Capital Management withdrew a net $108M in Q3 2022, closing 59 positions and reducing 52 holdings. Its most notable exit was Cardinal Health, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Invenomic Capital Management opened a new position in Zoom worth $17.2M.

  • Invenomic Capital Management's largest Q3 2022 buy was Zoom: 234,351 shares worth $17.2M.
  • Invenomic Capital Management added most to IPG Photonics in Q3 2022, an estimated $21.3M increase.
  • Invenomic Capital Management's biggest Q3 2022 reduction was Belden, cutting an estimated $13.5M.
  • Invenomic Capital Management fully exited Cardinal Health in Q3 2022, selling an estimated $17.9M.
  • Invenomic Capital Management's ten largest holdings make up 23% of its $1.16B portfolio in Q3 2022.
  • Invenomic Capital Management opened 58 new positions and closed 59 in Q3 2022.
  • Invenomic Capital Management's portfolio value fell 17% quarter-over-quarter to $1.16B.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.